Latest news with #NationalCancerControlAuthority
Libya Observer
10-05-2025
- Health
- Libya Observer
Officials detained in ongoing health procurement probe
Libyan authorities have detained two senior officials as part of a widening investigation into alleged irregularities in the procurement of medicines. The Head of the National Cancer Control Authority, Haider Al-Sayah, and the Chair of the General Tender Committee were ordered into custody by the Public Prosecutor's Office on Thursday. The charges relate to violations of contracting regulations in purchasing medications. According to the Attorney General's Office, the procurement process ignored legal guidelines and breached the contractual framework assigned to the committee. This follows the suspension of Acting Health Minister Ramadan Abu Janah, who is also under investigation after reportedly authorising medicine imports from Iraq outside the remit of the cancer authority. The probe has so far led to the detention of five individuals, including Abu Janah, the Director of the Pharmacy Department, key members of the Health Ministry's tender committees, and a pharmaceutical company representative. Tags: National Cancer Control Commission Attorney General
Libya Observer
03-05-2025
- Health
- Libya Observer
Cancer drug shipment sparks controversy amid minister's dismissal
The dismissed health minister, Ramadan Abu Janah, has defended a controversial cancer drug shipment from Iraq, stating it was requested directly by oncology hospitals. Speaking in a televised address published on his official Facebook page, Abu Janah clarified that the company involved in the deal is registered with the Health Ministry's pharmacy department and that all procurement steps were followed through the proper legal and administrative channels. He noted that the shipment has not yet entered Libya and remains unpaid, pending standard quality checks by the Food and Drug Control Authority. The National Cancer Control Authority, however, has distanced itself from the shipment. Its Director of International Cooperation, Abdulmunem Al-Barasi, reiterated the body had no involvement, saying: "We were neither consulted nor informed at any point." Abu Janah also criticized Prime Minister Abdulhamid Dbeibah's recent dismissal of health officials, describing it as unjust to two senior staff—Deputy Minister Tawfiq Al-Darsi and Nursing Director Fatima Al-Wafi—who, he said, had no role in the medication procurement. The Cancer Control Authority had previously denied importing any medications from Iraq or other Arab or Asian countries, calling for transparency in the ongoing investigation. Tags: Minister of Health National Cancer Control Commission
Shafaq News
30-04-2025
- Health
- Shafaq News
Controversy over Iraqi cancer drug imports: Libya Suspends Deputy PM
Shafaq News/ On Tuesday, Libya's interim Prime Minister Abdulhamid Dbeibah removed several officials from their roles in the Health Ministry over irregularities linked to the import of cancer treatment drugs. According to Al-Wasat, the decision followed reports that a shipment of oncology medication entered the country without the required authorization, in breach of Cabinet Resolution No. 963 of 2022, which grants sole import authority to the National Cancer Control Authority. Those suspended include Deputy Prime Minister Ramadan Abu Janah, Health Ministry Undersecretary Tofig Idris, Pharmacy Director Nadia Abu Subaa, Registration Head Nahed al-Makki, Local Tender Committee Chair Akram al-Fazzani, and Nursing Director Fatima al-Wafi. The move came shortly after Iraq announced the export of its first batch of domestically produced cancer drugs to Libya. The National Cancer Control Authority rejected the claim, maintaining that it procures medicines exclusively from certified suppliers in the United States and Europe. At a press briefing on April 29, Undersecretary Idris outlined the ministry's official procedures for ensuring the safety and quality of imported pharmaceuticals. The ministry also affirmed that all medications brought in through official channels undergo strict regulatory review and reiterated its responsibility for upholding public health standards. Later that day, the ministry confirmed that it had contracted a local firm to handle the import of the Iraqi-manufactured cancer drugs, following the earlier denial by the National Anti-Cancer Authority.
